FOR IMMEDIATE RELEASE
DES Pharma to Exhibit 17th World ADC San Diego 2026
PHILADELPHIA, PA — Sep. 15, 2026 — DES Pharma (Dynamic Engineering Solutions), a global partner in drug development, will host a booth at the 17th World ADC San Diego, taking place October 12–15, 2026, at the Town and Country Resort in San Diego, California. The DES Pharma team will be on site throughout the four-day event to connect with pharmaceutical and biotechnology leaders and discuss the evolving challenges of antibody-drug conjugate (ADC) development. DES Pharma will be exhibiting and can be found at booth 44.

World ADC San Diego brings together professionals across the ADC development landscape, from discovery and preclinical research through clinical development, process and analytical development, manufacturing, and supply chain. The 2026 event is expected to bring together more than 1,300 attendees from more than 400 companies.
Five DES Pharma Experts. One Integrated Perspective.
ADC development requires coordination across multiple disciplines, including biologics, highly potent small molecules, conjugation, analytical characterization, manufacturing, quality, and supply chain.
The DES Pharma team attending World ADC San Diego will bring an integrated CMC and engineering perspective to these challenges, helping companies identify practical solutions to development, scale-up, technology transfer, quality, and supply-chain needs.
“Our team is looking forward to being part of the ADC community in San Diego and engaging directly with companies working to advance the next generation of ADC therapies,” said Meade Medaugh, President, DES Pharma. “ADC development is inherently cross-functional. Success depends not only on the science, but also on how effectively process development, analytics, quality, manufacturing, and supply chain work together.”
Key ADC Topics at World ADC San Diego
During the conference, DES Pharma will be available to discuss challenges and opportunities including:
- Conjugation process development and DAR control — reaction design, process parameters, in-process controls, and control of drug-to-antibody ratio distribution.
- Analytical characterization and comparability — integrated analytical strategies and comparability planning for development and site changes.
- High-potency containment and occupational safety — containment strategies, occupational exposure considerations, and cleaning validation for cytotoxic payloads.
- Multi-site technology transfer — coordinating antibody production, conjugation, fill-finish, and release requirements across development partners.
- Clinical pharmacology strategy — exposure-response and dose selection, drug-drug interaction and organ impairment assessment for the payload, and alignment with FDA expectations for ADC clinical pharmacology.
- Bioanalytical strategy — analyte selection across conjugated antibody, total antibody, and unconjugated payload, ligand-binding and LC-MS/MS method development, and immunogenicity assessment.
- Linker-payload supply chain resilience — dual sourcing, supplier qualification, and contingency planning for high-potency materials.
Connecting Across the ADC Development Lifecycle
DES Pharma provides integrated support across program and process development, quality control and analytics, supply chain and procurement, quality assurance, and medical safety and pharmacovigilance.
The company’s multidisciplinary approach is designed to help pharmaceutical and biotechnology companies address complex development challenges while maintaining focus on quality, compliance, scalability, and speed.
“We believe the most productive conversations happen when technical challenges are viewed from the perspective of the entire development lifecycle,” added Meade Medaugh, President. “World ADC San Diego provides an excellent opportunity to exchange ideas, understand where the industry is heading, and explore how DES Pharma can support companies at different stages of their ADC programs.”
Meet DES Pharma in San Diego
The DES Pharma team will be at booth 44 and available for meetings throughout October 12–15, 2026 at the Town and Country Resort.
Companies attending World ADC San Diego are invited to schedule time with the DES Pharma team to discuss their ADC programs, development challenges, or CMC and supply-chain strategies.
Request a meeting: despharmaconsulting.com/adc-
- Event: 17th World ADC San Diego
- Dates: October 12–15, 2026
- Location: Town and Country Resort, San Diego, California
- Booth: #44

About DES Pharma
DES Pharma (Dynamic Engineering Solutions) is a global partner in drug development, providing integrated CMC, analytical, quality, and supply chain solutions to biotechnology and pharmaceutical companies. With a focus on speed, precision, and compliance, DES Pharma helps clients advance life-changing therapies efficiently and confidently.
Learn more: DES Pharma




